DCGI approves market authorisation to COVID-19 vaccine Covovax as heterologous booster dose for adults administered two doses of Covishield or Covaxin: Official sources

DCGI approves market authorisation to COVID-19 vaccine Covovax as heterologous booster dose for adults administered two doses of Covishield or Covaxin: Official sources.